EXHIBIT 11.1 SONUS PHARMACEUTICALS, INC. COMPUTATION OF NET INCOME (LOSS) PER SHARE
THREE MONTHS ENDED NINE MONTHS ENDED SEPTEMBER 30, SEPTEMBER 30, --------------------------------- --------------------------------- 1998 1997 1998 1997 ----------- ----------- ----------- ----------- BASIC EARNINGS PER SHARE: Net income (loss) ....................... $(2,048,648) $(1,122,176) $(8,413,476) $ 639,604 Weighted average common shares .......... 8,626,253 8,573,029 8,619,125 8,553,321 Basic earnings per share ............. $ (0.24) $ (0.13) $ (0.98) $ 0.07 DILUTED EARNINGS PER SHARE: Net income (loss) ....................... $(2,048,648) $(1,122,176) $(8,413,476) $ 639,604 Weighted average common shares - basic .. 8,626,253 8,753,029 8,619,125 8,553,321 Dilutive potential common shares ........ -- -- -- 1,003,850 ----------- ----------- ----------- ----------- Total ................................ 8,626,253 8,573,029 8,619,125 9,557,171 =========== =========== =========== =========== Diluted earnings per share ........... $ (0.24) $ (0.13) $ (0.98) $ 0.07
12